GI
JAZZ icon

GAMMA Investing’s Jazz Pharmaceuticals JAZZ Stock Holding History

GAMMA Investing’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$378K Buy
1,631
+224
+16% +$55.3K 0.01% 866
2026
Q2 		$339K Buy
1,407
+223
+19% +$48.9K 0.01% 878
2026
Q1 		$224K Buy
1,184
+172
+17% +$30.1K 0.01% 1033
2025
Q4 		$172K Buy
1,012
+357
+55% +$54.7K 0.01% 1150
2025
Q3 		$86.3K Buy
655
+154
+31% +$18.5K ﹤0.01% 1607
2025
Q2 		$53.2K Sell
501
-514
-51% -$55.8K ﹤0.01% 1901
2025
Q1 		$126K Buy
1,015
+395
+64% +$51.5K 0.01% 1071
2024
Q4 		$76.4K Buy
620
+206
+50% +$24.3K 0.01% 1316
2024
Q3 		$46.1K Buy
414
+121
+41% +$13.3K ﹤0.01% 1544
2024
Q2 		$31.3K Buy
293
+116
+66% +$12.8K ﹤0.01% 1540
2024
Q1 		$21.3K Buy
177
+74
+72% +$9.06K ﹤0.01% 1611
2023
Q4 		$12.6K Buy
+103
New +$12.9K ﹤0.01% 1776

Other funds holding JAZZ

ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
TFA
Toth Financial Advisory Leesburg, Virginia $1B AUM 19.18% 1-Year Est. Return
PC
Parrish Capital Kennesaw, Georgia $103M AUM 35.11% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
BONH
Bank of New Hampshire Laconia, New Hampshire $463M AUM 23.57% 1-Year Est. Return
VAG
VisionPoint Advisory Group Dallas, Texas $636M AUM 21.4% 1-Year Est. Return
YIA
YHB Investment Advisors West Hartford, Connecticut $1.59B AUM 21.04% 1-Year Est. Return

GAMMA Investing's JAZZ Position: Q3 2026 in Review

GAMMA Investing increased its Jazz Pharmaceuticals (JAZZ) stake by 16% in Q3 2026, buying an estimated $55.3K and bringing the position to 1,631 shares worth $378K. The position accounts for 0.01% of the portfolio, ranked #866.

GAMMA Investing first reported a position in JAZZ in Q4 2023 and has held it in 12 quarters since. 21 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • GAMMA Investing held 1,631 shares of Jazz Pharmaceuticals worth $378K as of Q3 2026.
  • GAMMA Investing bought 224 Jazz Pharmaceuticals shares in Q3 2026, an estimated $55.3K.
  • Jazz Pharmaceuticals made up 0.01% of GAMMA Investing's portfolio in Q3 2026, its #866 holding.
  • GAMMA Investing first reported a position in Jazz Pharmaceuticals in Q4 2023 and has held it in 12 quarters since.
  • 21 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.